皮膚発疹治療の世界市場

皮膚発疹治療の世界市場は2030年までに47億米ドルに達する見込み

2024年に36億米ドルと推定される皮膚発疹治療の世界市場は、2024～2030年の分析期間にCAGR 4.5%で成長し、2030年には47億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである副腎皮質ステロイドは、CAGR 3.8％を記録し、分析期間終了時には20億米ドルに達すると予測されます。免疫抑制剤セグメントの成長率は、分析期間中CAGR 3.7%と推定されます。

米国市場は9億7,120万米ドルと推定、中国はCAGR 7.1％で成長予測

米国の皮膚発疹治療市場は、2024年に9億7,120万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに9億370万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは7.1%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.2%と4.5%と予測されています。欧州では、ドイツがCAGR 2.9%で成長すると予測されています。

世界の「皮膚発疹治療」市場- 主要動向と促進要因のまとめ

皮膚発疹治療が皮膚科およびプライマリケアの中核となった理由

発赤、炎症、腫脹、水疱などの症状を示す皮疹は、世界的に最も一般的な皮膚科疾患の一つであり、あらゆる年齢層や地域の人々に影響を及ぼしています。その原因は、アレルギー反応、感染症（細菌、真菌、ウイルス）、自己免疫疾患、熱曝露から、湿疹、乾癬、皮膚炎などの慢性炎症性疾患まで、多岐にわたっています。発疹は目に見えやすく、しばしば不快なものであるため、生活の質や精神的な幸福に大きな影響を与え、効果的な治療法に対する緊急の需要を促しています。治療法は多岐にわたり、副腎皮質ステロイド外用薬、抗真菌薬、抗ヒスタミン薬、免疫調節薬、生物学的製剤のほか、重症例や持続性のある症例に対する全身療法もあります。伝染性膿痂疹や白癬のような感染症、麻疹や帯状疱疹のようなウイルス性発疹には、標的を絞った抗菌薬や抗ウイルス薬が必要であり、狼瘡や血管炎のような自己免疫関連の発疹には免疫抑制薬が必要です。アトピー性皮膚炎や接触性皮膚炎の増加は、環境汚染物質、アレルゲン、刺激物によって引き起こされることが多く、発疹治療は皮膚科、さらには一般診療の中心的な焦点となっています。消費者の意識の高まり、皮膚科治療へのアクセスの拡大、慢性および急性の発疹の発生率の増加により、安全で即効性があり、症状に特化した治療に対する需要は世界中で高まり続けています。

技術革新とカスタマイズはどのように皮膚発疹治療の将来を形成しているのか？

技術と医薬品の進歩は、従来の副腎皮質ステロイドや抗ヒスタミン剤から、より正確で長時間作用し、患者に優しい選択肢へと、皮疹の治療を再構築しています。局所治療薬は現在、ナノテクノロジーを駆使して開発されており、薬剤の浸透を改善し、全身への曝露を最小限に抑え、ステロイドの長期使用に伴う副作用を伴わずに標的を絞った緩和を実現しています。PDE4阻害薬やカルシニューリン阻害薬を含む非ステロイド性抗炎症薬の台頭は、敏感肌やステロイド抵抗性の患者に効果的な選択肢を提供しています。湿疹や乾癬のような慢性炎症性疾患に対しては、デュピルマブやインターロイキン阻害剤のような生物学的製剤が、免疫経路を直接調節することにより、画期的な治療効果をもたらしています。遺伝子、微生物、ライフスタイルのプロファイリングにより、臨床医が個々の誘因や肌タイプに基づいて治療計画をオーダーメイドできるパーソナライズド皮膚科学が台頭しています。また、AIを活用した診断ツールやモバイルアプリは、患者が発疹を自己評価し、バーチャルコンサルテーションを受けるのに役立ち、治療へのアクセスを加速させています。カモミール、アロエベラ、カレンデュラなどを配合したハーブや植物由来の製剤は、自然療法への需要が高まるにつれ、一般用医薬品（OTC）の発疹ケアに組み込まれつつあります。すべての処方において、敏感肌層や健康志向の消費者に対応するため、クリーンラベル、低刺激性、無香料製品の傾向が強まっています。

肌荒れ治療は、患者グループや臨床現場においてどのような影響を及ぼしているのか？

肌荒れ治療薬は、多様なヘルスケア環境や消費者セグメントにおいて、変革的な役割を果たしています。おむつかぶれ、ウイルス性発疹、湿疹が流行する小児科では、肌に優しい副腎皮質ステロイド、亜鉛ベースのクリーム、バリア軟膏が予防と治療の両面で広く使われています。高齢者では、加齢に伴う皮膚の菲薄化、薬物反応、免疫抑制により、発疹がより持続的かつ複雑になるため、副作用を避けるために薬理学的なバランスを注意深くとる必要があります。化学療法を受けている患者やHIV感染者などの免疫不全患者では、日和見感染や薬剤性皮膚炎に対処するための高度に専門的な治療が必要となります。旅行者や屋外で働く人々には、虫刺され、熱疹、日光による発疹を対象とした治療が不可欠です。病院や長期介護施設では、接着剤や褥瘡による接触性皮膚炎は、抗炎症療法や保湿療法で速やかに対処しないと慢性創傷に発展する可能性があります。コンシューマー・ウェルネス市場では、特に酒さ、脂漏性皮膚炎、にきび状皮疹の患者を対象に、皮疹の再発予防を目的としたスキンケア・レジメンに皮疹治療が組み込まれることが増えています。化学物質、ラテックス手袋、頻繁な手洗いなどにさらされることによって引き起こされる職場に関連した皮膚発疹も、特にヘルスケア、クリーニング、製造部門で注目されるようになっています。これらの多様な使用事例は、様々な臨床現場や生活環境における、急性の緩和から長期的な皮膚管理まで、発疹治療の機能横断的な性質を強調しています。

皮膚発疹治療市場の成長は、健康動向、皮膚科学イノベーション、消費者行動の変化を反映するいくつかの要因によって牽引されています。

主要な促進要因は、環境汚染、気候変動、アレルゲン、スキンケア製品や個人用保護具による刺激物への曝露の増加に関連した皮膚関連疾患の世界の増加です。アトピー性皮膚炎、乾癬、接触性皮膚炎などの慢性炎症性皮膚疾患の有病率の高まりは、処方箋強度の高い発疹治療薬と市販の発疹治療薬に対する持続的な需要を生み出しています。遠隔医療による皮膚科医療へのアクセスの増加、デジタル・プラットフォームによる皮膚の健康に対する意識の高まりが、早期診断と迅速な介入を促しています。新興市場では、所得の増加と都市化により、ブランド発疹クリーム、抗真菌薬、代替ハーブへの消費者のアクセスが拡大しています。医薬品の技術革新、特に免疫療法と生物製剤の分野では、重症で難治性の皮膚疾患に対する高価値の治療分野が開拓されつつあります。ステロイド温存剤、JAK阻害剤外用剤、配合剤の新規承認により、治療ポートフォリオがさらに多様化しています。一方、消費者の行動はクリーンビューティーやナチュラル志向にシフトしており、植物性製剤や非刺激性製剤を中心とした製品開発の波が押し寄せています。皮膚科の処方箋に健康保険が適用されるようになり、以前は処方箋が必要だった薬剤のOTC販売も拡大しています。医療需要、患者の期待、製品イノベーションなど、相互に関連するこれらの動向が、世界の皮膚発疹治療市場の堅調な多層的成長を牽引しています。

セグメント

治療タイプ（副腎皮質ホルモン剤、免疫抑制剤、抗ヒスタミン剤、抗真菌剤、その他の治療タイプ）、皮疹タイプ（接触性皮膚炎、アトピー性皮膚炎、乾癬、脂漏性皮膚炎、その他の皮疹タイプ）、流通チャネル（薬局、小売店、その他の流通チャネル）

調査対象企業の例（全39件）

• AbbVie Inc.
• Almirall, S.A.
• Amgen Inc.
• Arcutis Biotherapeutics
• Bausch Health Companies Inc.
• Bristol Myers Squibb
• Galderma S.A.
• GSK plc
• Johnson & Johnson
• LEO Pharma A/S
• Merck & Co., Inc.
• Mylan N.V.
• Novartis AG
• Perrigo Company plc
• Pfizer Inc.
• Regeneron Pharmaceuticals Inc.
• Sanofi
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• UCB S.A.

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・業界団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストを含む1万4,949人のエコノミストを追跡しています。当社の16,491を超えるレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Skin Rash Treatment Market to Reach US$4.7 Billion by 2030

The global market for Skin Rash Treatment estimated at US$3.6 Billion in the year 2024, is expected to reach US$4.7 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Corticosteroids, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$2.0 Billion by the end of the analysis period. Growth in the Immunosuppressants segment is estimated at 3.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$971.2 Million While China is Forecast to Grow at 7.1% CAGR

The Skin Rash Treatment market in the U.S. is estimated at US$971.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$903.7 Million by the year 2030 trailing a CAGR of 7.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 4.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Global "Skin Rash Treatment" Market - Key Trends & Drivers Summarized

Why Has Skin Rash Treatment Become A Core Focus In Dermatological And Primary Care?

Skin rashes-manifesting as redness, irritation, swelling, or blistering-are among the most common dermatological complaints globally, affecting individuals across all age groups and geographies. The causes are vast and multifactorial, ranging from allergic reactions, infections (bacterial, fungal, viral), autoimmune diseases, and heat exposure to chronic inflammatory conditions such as eczema, psoriasis, and dermatitis. Given their visible and often uncomfortable nature, rashes significantly impact quality of life and mental well-being, prompting urgent demand for effective treatment solutions. The treatment landscape is equally diverse, encompassing topical corticosteroids, antifungals, antihistamines, immunomodulators, and biologics, as well as systemic therapies for severe or persistent cases. Infections like impetigo and ringworm, or viral exanthems such as measles or shingles, require targeted antimicrobial or antiviral therapy, while autoimmune-related rashes like lupus or vasculitis demand immunosuppressants. The rise of atopic dermatitis and contact dermatitis-often triggered by environmental pollutants, allergens, and irritants-has made rash treatment a central focus of dermatology and even general practice. With heightened consumer awareness, expanding access to dermatologic care, and increasing incidence of both chronic and acute rashes, the demand for safe, fast-acting, and condition-specific treatments continues to grow across the globe.

How Are Innovation And Customization Shaping The Future Of Skin Rash Treatment?

Technological and pharmaceutical advances are reshaping the treatment of skin rashes, moving beyond traditional corticosteroids and antihistamines to more precise, long-acting, and patient-friendly options. Topical treatments are now being developed with nanotechnology to improve drug penetration, minimize systemic exposure, and provide targeted relief without the side effects of prolonged steroid use. The rise of non-steroidal anti-inflammatory agents, including PDE4 inhibitors and calcineurin inhibitors, is providing effective alternatives for patients with sensitive skin or steroid resistance. For chronic inflammatory conditions like eczema and psoriasis, biologics such as dupilumab and interleukin inhibitors are offering game-changing outcomes by directly modulating immune pathways. Personalized dermatology is on the rise, with genetic, microbial, and lifestyle profiling helping clinicians tailor treatment plans based on individual triggers and skin types. AI-powered diagnostic tools and mobile apps are also helping patients self-assess rashes and receive virtual consultations, accelerating access to treatment. Herbal and plant-based formulations-often enriched with chamomile, aloe vera, or calendula-are being integrated into over-the-counter (OTC) rash care as demand for natural remedies surges. Across all formulations, there is a growing trend toward clean-label, hypoallergenic, and fragrance-free products, catering to sensitive skin demographics and health-conscious consumers.

Where Are Skin Rash Treatments Creating Impact Across Patient Groups And Clinical Settings?

Skin rash treatments are playing a transformative role across diverse healthcare environments and consumer segments. In pediatrics, where diaper rash, viral exanthems, and eczema are prevalent, gentle corticosteroids, zinc-based creams, and barrier ointments are widely used both preventively and therapeutically. In geriatrics, age-related skin thinning, drug reactions, and immune suppression make rashes more persistent and complex, necessitating careful pharmacologic balancing to avoid adverse effects. Immunocompromised patients-such as those undergoing chemotherapy or living with HIV-require highly specialized treatments to address opportunistic infections and medication-induced dermatitis. For travelers and outdoor workers, treatments targeting insect bites, heat rashes, and sun-related eruptions remain essential. In hospitals and long-term care facilities, contact dermatitis from adhesives or pressure ulcers can develop into chronic wounds if not addressed promptly with anti-inflammatory or moisture-retentive therapies. In the consumer wellness market, rash treatments are increasingly bundled into skincare regimens aimed at preventing flare-ups, especially for people with rosacea, seborrheic dermatitis, or acneiform rashes. Workplace-related skin rashes-caused by exposure to chemicals, latex gloves, or frequent handwashing-are also a growing area of focus, particularly in healthcare, cleaning, and manufacturing sectors. These diverse use cases emphasize the cross-functional nature of rash treatment-from acute relief to long-term skin management across various clinical and lifestyle settings.

The Growth In The Skin Rash Treatment Market Is Driven By Several Factors That Reflect Health Trends, Dermatological Innovation, And Shifting Consumer Behavior

A key driver is the global rise in skin-related disorders linked to environmental pollution, climate change, allergens, and increased exposure to irritants from skincare products and personal protective equipment. The growing prevalence of chronic inflammatory skin diseases-such as atopic dermatitis, psoriasis, and contact dermatitis-has created sustained demand for prescription-strength and over-the-counter rash treatments alike. Increased access to dermatology care through telehealth, along with heightened awareness of skin health via digital platforms, is fueling earlier diagnosis and faster intervention. In emerging markets, rising incomes and urbanization are expanding consumer access to branded rash creams, antifungals, and herbal alternatives. Pharmaceutical innovation, particularly in the area of immunotherapy and biologics, is unlocking high-value treatment segments for severe and refractory skin conditions. Regulatory approvals of new steroid-sparing agents, topical JAK inhibitors, and combination products are further diversifying the treatment portfolio. Meanwhile, consumer behavior is shifting toward clean beauty and natural solutions, prompting a wave of product development around botanical and non-irritant formulations. Health insurance coverage for dermatological prescriptions and expanding OTC availability of formerly Rx-only medications are also broadening access. These interconnected trends-spanning medical demand, patient expectations, and product innovation-are collectively driving robust, multi-tiered growth in the global skin rash treatment market.

SCOPE OF STUDY:

The report analyzes the Skin Rash Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment Type (Corticosteroids, Immunosuppressants, Antihistamines, Antifungals, Other Treatment Types); Skin Rash Type (Contact Dermatitis, Atopic Dermatitis, Psoriasis, Seborrheic Dermatitis, Other Skin Rash Types); Distribution Channel (Pharmacies, Retail Stores, Other Distribution Channels)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 39 Featured) -

• AbbVie Inc.
• Almirall, S.A.
• Amgen Inc.
• Arcutis Biotherapeutics
• Bausch Health Companies Inc.
• Bristol Myers Squibb
• Galderma S.A.
• GSK plc
• Johnson & Johnson
• LEO Pharma A/S
• Merck & Co., Inc.
• Mylan N.V.
• Novartis AG
• Perrigo Company plc
• Pfizer Inc.
• Regeneron Pharmaceuticals Inc.
• Sanofi
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• UCB S.A.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Skin Rash Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Allergic Skin Reactions and Eczema Spurs Demand for Topical Rash Treatments
  • Growth in Awareness Campaigns and Self-Diagnosis Accelerates OTC Product Adoption
  • Increasing Urban Pollution and Chemical Exposure Expands the Market for Anti-Rash Solutions
  • Rise in Atopic Dermatitis Among Children Drives Pediatric Treatment Segment Growth
  • Shift Toward Natural and Herbal Remedies Strengthens Consumer Preference for Organic Formulations
  • Evolving Consumer Habits Toward Preventive Skincare Drives Regular Product Use
  • Pharmaceutical Innovation in Steroid-Free Creams Expands Product Portfolios
  • Teledermatology and E-Pharmacy Platforms Enhance Access to Rash Treatments
  • Growth in Travel and Outdoor Activities Spurs Seasonal Demand for Skin Rash Products
  • Clinical R&D in Immunomodulators and Biologics Drives Prescription Product Adoption
  • Increasing Focus on Skin Barrier Restoration Strengthens Demand for Moisturizing Rash Therapies
  • Expanding Geriatric Population with Sensitive Skin Sustains Long-Term Market Growth
  • Cross-Promotion With Personal Care Brands Creates New Retail Opportunities
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Skin Rash Treatment Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Skin Rash Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Skin Rash Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Skin Rash Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Corticosteroids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Corticosteroids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Corticosteroids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Immunosuppressants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Immunosuppressants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Immunosuppressants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Antihistamines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Antihistamines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Antihistamines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Antifungals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Antifungals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Antifungals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Other Treatment Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Skin Rash Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Skin Rash Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Other Skin Rash Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Contact Dermatitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Contact Dermatitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Contact Dermatitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Atopic Dermatitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Atopic Dermatitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Atopic Dermatitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Psoriasis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Psoriasis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Psoriasis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Seborrheic Dermatitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Seborrheic Dermatitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Seborrheic Dermatitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Retail Stores by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Retail Stores by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Retail Stores by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Other Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Skin Rash Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 44: USA Recent Past, Current & Future Analysis for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Skin Rash Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Skin Rash Treatment by Skin Rash Type - Percentage Breakdown of Value Sales for Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Skin Rash Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies, Retail Stores and Other Distribution Channels for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Skin Rash Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Skin Rash Treatment by Skin Rash Type - Percentage Breakdown of Value Sales for Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Skin Rash Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies, Retail Stores and Other Distribution Channels for the Years 2015, 2025 & 2030
• JAPAN
  • Skin Rash Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Skin Rash Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Skin Rash Treatment by Skin Rash Type - Percentage Breakdown of Value Sales for Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Skin Rash Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies, Retail Stores and Other Distribution Channels for the Years 2015, 2025 & 2030
• CHINA
  • Skin Rash Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 71: China Recent Past, Current & Future Analysis for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Skin Rash Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Skin Rash Treatment by Skin Rash Type - Percentage Breakdown of Value Sales for Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Skin Rash Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies, Retail Stores and Other Distribution Channels for the Years 2015, 2025 & 2030
• EUROPE
  • Skin Rash Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Skin Rash Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Skin Rash Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Skin Rash Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Skin Rash Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Skin Rash Treatment by Skin Rash Type - Percentage Breakdown of Value Sales for Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis for the Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Skin Rash Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies, Retail Stores and Other Distribution Channels for the Years 2015, 2025 & 2030
• FRANCE
  • Skin Rash Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 92: France Recent Past, Current & Future Analysis for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for Skin Rash Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for Skin Rash Treatment by Skin Rash Type - Percentage Breakdown of Value Sales for Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis for the Years 2015, 2025 & 2030
  • TABLE 98: France Recent Past, Current & Future Analysis for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: France 15-Year Perspective for Skin Rash Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies, Retail Stores and Other Distribution Channels for the Years 2015, 2025 & 2030
• GERMANY
  • Skin Rash Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for Skin Rash Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for Skin Rash Treatment by Skin Rash Type - Percentage Breakdown of Value Sales for Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis for the Years 2015, 2025 & 2030
  • TABLE 107: Germany Recent Past, Current & Future Analysis for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Germany Historic Review for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Germany 15-Year Perspective for Skin Rash Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies, Retail Stores and Other Distribution Channels for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for Skin Rash Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for Skin Rash Treatment by Skin Rash Type - Percentage Breakdown of Value Sales for Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis for the Years 2015, 2025 & 2030
  • TABLE 116: Italy Recent Past, Current & Future Analysis for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Italy 15-Year Perspective for Skin Rash Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies, Retail Stores and Other Distribution Channels for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Skin Rash Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 119: UK Recent Past, Current & Future Analysis for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for Skin Rash Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for Skin Rash Treatment by Skin Rash Type - Percentage Breakdown of Value Sales for Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis for the Years 2015, 2025 & 2030
  • TABLE 125: UK Recent Past, Current & Future Analysis for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: UK 15-Year Perspective for Skin Rash Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies, Retail Stores and Other Distribution Channels for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for Skin Rash Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for Skin Rash Treatment by Skin Rash Type - Percentage Breakdown of Value Sales for Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis for the Years 2015, 2025 & 2030
  • TABLE 134: Spain Recent Past, Current & Future Analysis for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Spain Historic Review for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Spain 15-Year Perspective for Skin Rash Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies, Retail Stores and Other Distribution Channels for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for Skin Rash Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for Skin Rash Treatment by Skin Rash Type - Percentage Breakdown of Value Sales for Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis for the Years 2015, 2025 & 2030
  • TABLE 143: Russia Recent Past, Current & Future Analysis for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Russia Historic Review for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Russia 15-Year Perspective for Skin Rash Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies, Retail Stores and Other Distribution Channels for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for Skin Rash Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for Skin Rash Treatment by Skin Rash Type - Percentage Breakdown of Value Sales for Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis for the Years 2015, 2025 & 2030
  • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Rest of Europe Historic Review for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Rest of Europe 15-Year Perspective for Skin Rash Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies, Retail Stores and Other Distribution Channels for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Skin Rash Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Skin Rash Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Skin Rash Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Skin Rash Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Skin Rash Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Skin Rash Treatment by Skin Rash Type - Percentage Breakdown of Value Sales for Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis for the Years 2015, 2025 & 2030
  • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Asia-Pacific Historic Review for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Asia-Pacific 15-Year Perspective for Skin Rash Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies, Retail Stores and Other Distribution Channels for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Skin Rash Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for Skin Rash Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for Skin Rash Treatment by Skin Rash Type - Percentage Breakdown of Value Sales for Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis for the Years 2015, 2025 & 2030
  • TABLE 173: Australia Recent Past, Current & Future Analysis for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Australia Historic Review for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Australia 15-Year Perspective for Skin Rash Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies, Retail Stores and Other Distribution Channels for the Years 2015, 2025 & 2030
• INDIA
  • Skin Rash Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 176: India Recent Past, Current & Future Analysis for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for Skin Rash Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for Skin Rash Treatment by Skin Rash Type - Percentage Breakdown of Value Sales for Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis for the Years 2015, 2025 & 2030
  • TABLE 182: India Recent Past, Current & Future Analysis for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: India Historic Review for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: India 15-Year Perspective for Skin Rash Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies, Retail Stores and Other Distribution Channels for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for Skin Rash Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for Skin Rash Treatment by Skin Rash Type - Percentage Breakdown of Value Sales for Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis for the Years 2015, 2025 & 2030
  • TABLE 191: South Korea Recent Past, Current & Future Analysis for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: South Korea Historic Review for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: South Korea 15-Year Perspective for Skin Rash Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies, Retail Stores and Other Distribution Channels for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Skin Rash Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Skin Rash Treatment by Skin Rash Type - Percentage Breakdown of Value Sales for Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis for the Years 2015, 2025 & 2030
  • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Asia-Pacific Historic Review for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Skin Rash Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies, Retail Stores and Other Distribution Channels for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Skin Rash Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Skin Rash Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Skin Rash Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Skin Rash Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Skin Rash Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Skin Rash Treatment by Skin Rash Type - Percentage Breakdown of Value Sales for Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis for the Years 2015, 2025 & 2030
  • TABLE 212: Latin America Recent Past, Current & Future Analysis for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Latin America Historic Review for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Latin America 15-Year Perspective for Skin Rash Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies, Retail Stores and Other Distribution Channels for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for Skin Rash Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for Skin Rash Treatment by Skin Rash Type - Percentage Breakdown of Value Sales for Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis for the Years 2015, 2025 & 2030
  • TABLE 221: Argentina Recent Past, Current & Future Analysis for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Argentina Historic Review for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Argentina 15-Year Perspective for Skin Rash Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies, Retail Stores and Other Distribution Channels for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for Skin Rash Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for Skin Rash Treatment by Skin Rash Type - Percentage Breakdown of Value Sales for Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis for the Years 2015, 2025 & 2030
  • TABLE 230: Brazil Recent Past, Current & Future Analysis for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Brazil Historic Review for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Brazil 15-Year Perspective for Skin Rash Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies, Retail Stores and Other Distribution Channels for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for Skin Rash Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for Skin Rash Treatment by Skin Rash Type - Percentage Breakdown of Value Sales for Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis for the Years 2015, 2025 & 2030
  • TABLE 239: Mexico Recent Past, Current & Future Analysis for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Mexico Historic Review for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Mexico 15-Year Perspective for Skin Rash Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies, Retail Stores and Other Distribution Channels for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for Skin Rash Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for Skin Rash Treatment by Skin Rash Type - Percentage Breakdown of Value Sales for Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Latin America Historic Review for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Latin America 15-Year Perspective for Skin Rash Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies, Retail Stores and Other Distribution Channels for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Skin Rash Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Skin Rash Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Skin Rash Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Skin Rash Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Skin Rash Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Skin Rash Treatment by Skin Rash Type - Percentage Breakdown of Value Sales for Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis for the Years 2015, 2025 & 2030
  • TABLE 260: Middle East Recent Past, Current & Future Analysis for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Middle East Historic Review for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Middle East 15-Year Perspective for Skin Rash Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies, Retail Stores and Other Distribution Channels for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for Skin Rash Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for Skin Rash Treatment by Skin Rash Type - Percentage Breakdown of Value Sales for Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis for the Years 2015, 2025 & 2030
  • TABLE 269: Iran Recent Past, Current & Future Analysis for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Iran Historic Review for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Iran 15-Year Perspective for Skin Rash Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies, Retail Stores and Other Distribution Channels for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for Skin Rash Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for Skin Rash Treatment by Skin Rash Type - Percentage Breakdown of Value Sales for Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis for the Years 2015, 2025 & 2030
  • TABLE 278: Israel Recent Past, Current & Future Analysis for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Israel Historic Review for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Israel 15-Year Perspective for Skin Rash Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies, Retail Stores and Other Distribution Channels for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for Skin Rash Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for Skin Rash Treatment by Skin Rash Type - Percentage Breakdown of Value Sales for Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis for the Years 2015, 2025 & 2030
  • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Saudi Arabia Historic Review for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Saudi Arabia 15-Year Perspective for Skin Rash Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies, Retail Stores and Other Distribution Channels for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for Skin Rash Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for Skin Rash Treatment by Skin Rash Type - Percentage Breakdown of Value Sales for Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis for the Years 2015, 2025 & 2030
  • TABLE 296: UAE Recent Past, Current & Future Analysis for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: UAE Historic Review for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: UAE 15-Year Perspective for Skin Rash Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies, Retail Stores and Other Distribution Channels for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for Skin Rash Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for Skin Rash Treatment by Skin Rash Type - Percentage Breakdown of Value Sales for Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Middle East Historic Review for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Middle East 15-Year Perspective for Skin Rash Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies, Retail Stores and Other Distribution Channels for the Years 2015, 2025 & 2030
• AFRICA
  • Skin Rash Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Skin Rash Treatment by Treatment Type - Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for Skin Rash Treatment by Treatment Type - Percentage Breakdown of Value Sales for Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Skin Rash Treatment by Skin Rash Type - Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for Skin Rash Treatment by Skin Rash Type - Percentage Breakdown of Value Sales for Other Skin Rash Types, Contact Dermatitis, Atopic Dermatitis, Psoriasis and Seborrheic Dermatitis for the Years 2015, 2025 & 2030
  • TABLE 314: Africa Recent Past, Current & Future Analysis for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Africa Historic Review for Skin Rash Treatment by Distribution Channel - Pharmacies, Retail Stores and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Africa 15-Year Perspective for Skin Rash Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies, Retail Stores and Other Distribution Channels for the Years 2015, 2025 & 2030

IV. COMPETITION